Literature DB >> 29210106

Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.

Sophie Girerd1,2, Nicolas Girerd2, Kevin Duarte2, Magali Giral3, Christophe Legendre4, Georges Mourad5, Valérie Garrigue5, Emmanuel Morelon6, Fanny Buron6, Nassim Kamar7, Arnaud Del Bello7, Marc Ladrière1, Michèle Kessler1, Luc Frimat1.   

Abstract

The impact of preemptive second kidney transplantation (2KT) on graft and patient survival is poorly established. The association between preemptive 2KT (p2KT, N = 93) and outcomes was estimated in a multicenter French cohort of 2KT (N = 1314) recipients using propensity score methods. During the follow-up, there were 274 returns to dialysis and 134 deaths. p2KT was associated with lower death-censored graft loss (HR = 0.39 [0.18-0.88], P = 0.024) and graft failure from any cause including death (HR = 0.42 [0.22-0.80], P = 0.008). Similar associations were observed for death with a functioning graft, although not reaching statistical significance (HR = 0.47 [0.17-1.26], P = 0.13). There was a significant interaction between donor type and p2KT (P for interaction = 0.016). Indeed, p2KT was not significantly associated with the risk of graft failure from any cause including death in living donor 2KT (P = 0.39), whereas the association was substantial in the deceased donor subset (HR = 0.30 [0.14-0.64], P = 0.002). Of note, the adjusted graft survival of p2KT with deceased donor paralleled that of 2KT with living donor, either preemptive or not (93.8% vs. 88.6% at 4 years and 76.1% vs. 70.5% at 8 years, P = 0.13). This large French multicenter study analyzed using propensity scores suggests that p2KT is associated with better graft prognosis.
© 2017 Steunstichting ESOT.

Entities:  

Keywords:  kidney transplantation; living donor; preemptive; retransplantation; second transplantation; survival

Mesh:

Year:  2017        PMID: 29210106     DOI: 10.1111/tri.13105

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

1.  Waiting Time for Second Kidney Transplantation and Mortality.

Authors:  Alexander Kainz; Michael Kammer; Roman Reindl-Schwaighofer; Susanne Strohmaier; Vojtěch Petr; Ondrej Viklicky; Daniel Abramowicz; Marcel Naik; Gert Mayer; Rainer Oberbauer
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-29       Impact factor: 8.237

2.  Disparities in Access to Preemptive Repeat Kidney Transplant: Still Missing the Mark?

Authors:  Amanda J Vinson; Bryce A Kiberd; Kenneth West; Roslyn B Mannon; Bethany J Foster; Karthik K Tennankore
Journal:  Kidney360       Date:  2021-10-20

3.  Returning to dialysis after kidney allograft loss: conflicting survival benefit beyond transplant-naïve maintenance dialysis patients.

Authors:  Ekamol Tantisattamo; Umberto Maggiore
Journal:  J Nephrol       Date:  2022-01       Impact factor: 3.902

4.  A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment.

Authors:  Miriam C Banas; Georg A Böhmig; Ondrej Viklicky; Lionel P Rostaing; Thomas Jouve; Lluis Guirado; Carme Facundo; Oriol Bestard; Hermann-Josef Gröne; Kazuhiro Kobayashi; Vladimir Hanzal; Franz Josef Putz; Daniel Zecher; Tobias Bergler; Sindy Neumann; Victoria Rothe; Amauri G Schwäble Santamaria; Eric Schiffer; Bernhard Banas
Journal:  Front Med (Lausanne)       Date:  2022-01-07

5.  Association between kidney retransplantation and survival according to age in the French national cohort of dialysis patients.

Authors:  Sophie Girerd; Kevin Duarte; Cécile Couchoud; Emmanuelle Laurain; Cécile Courivaud; Marc Bauwens; Michèle Kessler; Luc Frimat; Nicolas Girerd
Journal:  Am J Transplant       Date:  2022-05-24       Impact factor: 9.369

Review 6.  Strategies to Overcome HLA Sensitization and Improve Access to Retransplantation after Kidney Graft Loss.

Authors:  Rita Leal; Clara Pardinhas; António Martinho; Helena Oliveira Sá; Arnaldo Figueiredo; Rui Alves
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

Review 7.  Management of chronic renal allograft dysfunction and when to re-transplant.

Authors:  Richard J Baker; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2018-07-23       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.